Johnson & Johnson’s $4.5 Billion Registered Notes Offering

Cravath represented the underwriters, led by Bank of America Merrill Lynch, Goldman Sachs & Co. LLC, J.P. Morgan Securities, Citigroup and Deutsche Bank Securities, in connection with the $4.5 billion registered notes offering of Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The company, led by Alex Gorsky, is based in US.

The transaction closed on November 10, 2017.

The Cravath team included partner Craig F. Arcella (Picture) and associate Alexander E. Shiekman. Katharine A. Patterson also worked on this matter.


Involved fees earner: Craig Arcella – Cravath Swaine & Moore; Alexander Shiekman – Cravath Swaine & Moore;

Law Firms: Cravath Swaine & Moore;

Clients: Bank of America Merrill Lynch; Citigroup Inc.; Deutsche Bank Securities; Goldman, Sachs & Co.; JP Morgan Securities;



Author: Ambrogio Visconti